0001821825-24-000033.txt : 20240402 0001821825-24-000033.hdr.sgml : 20240402 20240402162936 ACCESSION NUMBER: 0001821825-24-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240329 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ali Kevin CENTRAL INDEX KEY: 0001859698 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40235 FILM NUMBER: 24814713 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organon & Co. CENTRAL INDEX KEY: 0001821825 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464838035 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 551-430-6000 MAIL ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 4 1 wk-form4_1712089757.xml FORM 4 X0508 4 2024-03-29 0 0001821825 Organon & Co. OGN 0001859698 Ali Kevin C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33 JERSEY CITY NJ 07032 1 1 0 0 Chief Executive Officer 0 Restricted Stock Units 2024-03-29 4 A 0 146276 0 A 2025-03-29 2027-03-29 Common Stock 146276 146276 D Stock Option (right to buy) 18.80 2024-03-29 4 A 0 599128 0 A 2025-03-29 2027-03-29 Common Stock 599128 599128 D The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027. The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027. /s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali 2024-04-02